HSDT — Solana Company

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Chart, dilution, float and news for HSDT in the TickerWise workspace.

Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and acquiring innovative, non-invasive platform technologies. These technologies are designed to enhance the brain's intrinsic capacity for self-healing and mitigate the effects of neurological diseases or trauma. A prime example of their work is the development of an investigational portable neuromodulation stimulator. This device uniquely delivers neurostimulation through the tongue. Clinical studies have indicated that this approach significantly enhances the efficacy of physical exercises for individuals experiencing neurological symptoms stemming from conditions like disease or trauma, including mild-to-moderate traumatic brain injury. Established on March 13, 2014, Solana Co. maintains its headquarters in Newtown, Pennsylvania.

Company profile

• Sector: Financial Services
• Industry: Asset Management
• Country: US
• Exchange: NASDAQ Capital Market
• Employees: 21
• Website: https://www.solanacompany.co

Latest SEC filings for HSDT

• 2026-09-30424B5
• 2026-08-1410-Q
• 2026-08-148-K
• 2026-05-298-K
• 2026-05-29424B5
• 2026-05-228-K
• 2026-05-15SCHEDULE 13G/A
• 2026-05-158-K
• 2026-05-1510-Q
• 2026-04-27424B5

Latest HSDT news

• 2026-10-02Solana Company (HSDT) Now Trades Above Golden Cross: Time to Buy? Read article
• 2026-09-30Solana Company (NASDAQ: HSDT) Announces Pricing of $15 Million Registered Direct Offering with a Global Institutional Investor Read article

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Educational tool only — not investment advice.